Drugs / Quinacrine
Quinacrine
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01839955 | Sep 2013 → Oct 2016 | non-small cell lung carcinoma | Neelesh Sharma MD PhD | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01844076 | Jan 2016 → Aug 2019 | colorectal adenocarcinoma | Fox Chase Cancer Center | Terminated | No outcome recorded |
| Phase 24 trials · 1 missed | ||||||
| Phase 2 | NCT07694336 | Jun 2026 → Jun 2028 expected | cutaneous lupus erythematosus | Victoria Werth | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT00574483 | Nov 2007 → Jan 2008 | renal cell carcinoma | Cleveland BioLabs | Withdrawn | No outcome recorded |
| Phase 2 | NCT00417274 | Dec 2006 → May 2008 | prostate cancer | Cleveland BioLabs | Completed | No outcome recorded |
| Phase 2 | NCT00183092 | Apr 2005 → Jun 2012 | Creutzfeldt Jacob disease | University of California, San Francisco | Completed | Missed primary |
| Phase not applicable1 trial | ||||||
| — | NCT00104663 | Jun 2004 → Mar 2007 | human prion disease | Medical Research Council | Completed | No outcome recorded |
Evidence & citations 17 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quinacrine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00104663 ↗ |
| Known as | Atabrine | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | Atabrine hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | GNF-Pf-5448 | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | Mepacrina | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | Mepacrine | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | Mepacrine hydrochloride | “Quinacrine (Mepacrine hydrochloride)” NCT00104663 ↗ |
| Known as | Mepacrine hydrochloride anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | Mepacrine hydrochloride dihydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | NSC-14229 | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | NSC-757307 | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | quinacrine dihydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01839955 ↗ |
| Known as | Quinacrine dihydrochloride dihydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | Quinacrine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Known as | QUINACRINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL7568 ↗ |
| Modality | Small molecule | — CHEMBL7568 ↗ |
| Route | Oral | “100mg by mouth three times a day” NCT00183092 ↗ |